laropiprant; nicotinic acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for laropiprant; nicotinic acid, covering 2013-05-16 to 2013-05-16. Get the full timeline:
Most recent: EMA Withdrawn: Trevaclyn (laropiprant;nicotinic acid) — Merck Sharp Dohme Ltd